SOLIFENACIN SUCCINATE
| Brand name | VESICARE LS |
|---|---|
| Active ingredient | SOLIFENACIN SUCCINATE |
| Strength | 1MG/ML |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2020 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9918970 | May 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.